Search - tctmd.com

Displaying 841 - 860 of 1120

Sort: Relevancy | Date

Presentation ECHO 2013

Echocardiography in Congenital and Structural Heart Disease: Assessment of Device – Repaired Patients

Presenter: Robert J. Sommer

April 05, 2013

Presentation ECHO 2013

Cardiac Magnetic Resonance Imaging in the Adult Congenital Patient

Presenter: Wyman W. Lai

April 05, 2013

Presentation ECHO 2013

Approach to Congenital Heart Disease: The Unoperated Adult

Presenter: Karen Stout

April 05, 2013

Presentation ECHO 2013

Approach to Congenital Heart Disease: The Postoperative Adult

Presenter: Karen Stout

April 05, 2013

Presentation ECHO 2013

Hypertrophic Cardiomyopathy

Presenter: Mario J. Garcia

April 04, 2013

Presentation ECHO 2013

When (and how) to use Stress Testing in Valvular Heart Disease

Presenter: Jae K. Oh

April 03, 2013

Presentation ECHO 2013

The Role of 3D Echo in Valvular Heart Disease

Presenter: Linda D. Gillam

April 03, 2013

Presentation ECHO 2013

Right Heart Valvular Disease: When to Intervene

Presenter: Linda D. Gillam

April 03, 2013

Presentation ECHO 2013

Quantifying the Right Heart: Basic and Advanced Measurements

Presenter: Michael H. Picard

April 03, 2013

Presentation ECHO 2013

Quantifying Myocardial Mechanics: Strain and Torsion

Presenter: James D. Thomas

April 03, 2013

Presentation ECHO 2013

Echocardiography for Assessment of Prosthetic Heart Valves

Presenter: Fletcher A. Miller Jr.

April 03, 2013

Presentation ECHO 2013

Asymptomatic Valvular Disease: When to Intervene

Presenter: Neil J. Weissman

April 03, 2013

Presentation ECHO 2013

Aortic Stenosis Quantitation: It’s Not All About the Gradient

Presenter: Philippe Pibarot

April 03, 2013

News Daily News

Revascularization Can Reverse Some Myocardial Damage, CMR Imaging Suggests

L.A. McKeown

March 09, 2013

News Daily News

La Revascularización puede Revertir Parte del Daño Miocárdico, según las Imágenes RMC

L.A. McKeown

March 09, 2013

Presentation

Regional Myocardial Thinning and Relationship with Myocardial Scarring in CAD Patients

Presenter: D. J. Shah

March 04, 2013

Presentation TCT 2013

Mid-term Outcomes of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in Patients with Sigmoid versus Neutral Ventricular Septum

Presenter: Josef Veselka, Pavol Tomasov, David Zemanek

January 31, 2013

Presentation TCT 2013

Functional Performance and Structural Maturation of Decellularised Pericardial Valves in Central Venous Position: An Experimental Study

Presenter: Alexander Lauten, Adrian Laube, Markus Ferrari, Harald Schubert, Sabine Bischoff, Arthur Lichtenberg, Hans Figulla, Payam Akhyari

January 31, 2013

Presentation TCT 2013

Complications of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy with Focus on Complete Heart Block: A European Multicenter Study

Presenter: Josef Veselka, Thorsten Lawrenz, Christoph Stellbrink, David Zemanek, Marian Branny, Jaroslav Januska, Ladislav Groch, Pawel Dimitrow, Jan Krejci, Maciej Dabrowski, Stanislav Mizera, Horst Kuhn

January 31, 2013

Presentation Cell Therapy 2013

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Presenter: Leslie Miller

January 24, 2013

Advertisement

Echocardiography in Congenital and Structural Heart Disease: Assessment of Device – Repaired Patients

Cardiac Magnetic Resonance Imaging in the Adult Congenital Patient

Approach to Congenital Heart Disease: The Unoperated Adult

Approach to Congenital Heart Disease: The Postoperative Adult

Hypertrophic Cardiomyopathy

When (and how) to use Stress Testing in Valvular Heart Disease

The Role of 3D Echo in Valvular Heart Disease

Right Heart Valvular Disease: When to Intervene

Quantifying the Right Heart: Basic and Advanced Measurements

Quantifying Myocardial Mechanics: Strain and Torsion

Echocardiography for Assessment of Prosthetic Heart Valves

Asymptomatic Valvular Disease: When to Intervene

Aortic Stenosis Quantitation: It’s Not All About the Gradient

Revascularization Can Reverse Some Myocardial Damage, CMR Imaging Suggests

La Revascularización puede Revertir Parte del Daño Miocárdico, según las Imágenes RMC

Regional Myocardial Thinning and Relationship with Myocardial Scarring in CAD Patients

Mid-term Outcomes of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in Patients with Sigmoid versus Neutral Ventricular Septum

Functional Performance and Structural Maturation of Decellularised Pericardial Valves in Central Venous Position: An Experimental Study

Complications of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy with Focus on Complete Heart Block: A European Multicenter Study

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content